Header

Header

Clovis

Latest News

December 12, 2022
145

Clovis Oncology Files for Chapter 11 Protection and Enters into Agreement to Sell FAP-2286
Latest News

November 9, 2022
149

Clovis Oncology warns of likely bankruptcy filing
Latest News

September 11, 2022
151

Clovis Oncology’s Rubraca® (Rucaparib) as First-Line Maintenance Treatment Improves Progression-Free Survival in Women with Advanced Ovarian Cancer Across Disease Risk Subgroups
Latest News

December 4, 2018
129

Clovis Oncology Announces Positive Outcome in European Opposition Proceeding Related to Rubraca®
Latest News

October 20, 2018
131

STAT Plus: Clovis, with new study data, hopes to be first to develop a PARP for prostate cancer
Latest News

September 19, 2018
144

STAT Plus: Clovis Oncology pays $20 million to settle charges of misleading investors
Latest News

August 8, 2018
135

Clovis Oncology Announces First Patient Enrolled in the Phase 3 ATHENA Trial